Your browser doesn't support javascript.
loading
Factors affecting turnaround time of SARS-CoV-2 sequencing for inpatient infection prevention and control decision making: analysis of data from the COG-UK HOCI study.
Colton, H; Parker, M D; Stirrup, O; Blackstone, J; Loose, M; McClure, C P; Roy, S; Williams, C; McLeod, J; Smith, D; Taha, Y; Zhang, P; Hsu, S N; Kele, B; Harris, K; Mapp, F; Williams, R; Flowers, P; Breuer, J; Partridge, D G; de Silva, T I.
Affiliation
  • Colton H; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Directorate of Laboratory Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. Electronic address: h.colton@sheffield.ac.uk.
  • Parker MD; Sheffield Biomedical Research Centre, University of Sheffield, Sheffield, UK; Sheffield Bioinformatics Core, University of Sheffield, Sheffield, UK.
  • Stirrup O; Institute for Global Health, University College London, London, UK.
  • Blackstone J; The Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Loose M; School of Life Sciences, University of Nottingham, Nottingham, UK.
  • McClure CP; School of Life Sciences, University of Nottingham, Nottingham, UK.
  • Roy S; Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.
  • Williams C; Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.
  • McLeod J; School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.
  • Smith D; Department of Applied Biology, Cellular and Molecular Sciences/Microbiology Group, Northumbria University, Newcastle, UK.
  • Taha Y; Department of Infection and Tropical Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
  • Zhang P; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
  • Hsu SN; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Sheffield Bioinformatics Core, University of Sheffield, Sheffield, UK.
  • Kele B; Virology Department, East and South East London Pathology Partnership, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Harris K; Virology Department, East and South East London Pathology Partnership, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Mapp F; Institute for Global Health, University College London, London, UK.
  • Williams R; Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.
  • Flowers P; School of Psychological Sciences and Health, University of Strathclyde, Glasgow, UK.
  • Breuer J; Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.
  • Partridge DG; Directorate of Laboratory Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • de Silva TI; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
J Hosp Infect ; 131: 34-42, 2023 Jan.
Article de En | MEDLINE | ID: mdl-36228768
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Type d'étude: Prognostic_studies / Qualitative_research Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: J Hosp Infect Année: 2023 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: SARS-CoV-2 / COVID-19 Type d'étude: Prognostic_studies / Qualitative_research Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: J Hosp Infect Année: 2023 Type de document: Article